Biology – Page 44
-
FeatureBeer: Music to your taste buds
Andy Extance goes on tour in the UK and Belgium and compares the science behind the different processes used by craft and mass brewers
-
-
-
ResearchBacteria build non-natural proteins using non-natural DNA
Semi-synthetic organism shows there is nothing unique about the chemistry of life as we know it
-
-
ResearchScrutiny of SmartFlares raises questions over RNA probes
Merck Millipore technology for detecting specific RNAs may not live up to claims
-
ReviewThe genome factor: what the social genomics revolution reveals about ourselves, our history and the future
Exploring the use of genetics in social policy
-
PodcastPolybutene
Kit Chapman discovers the compound that blighted Nixon’s second presidential inauguration by littering the route with dead pigeons
-
ResearchError-free next-generation DNA sequencing pioneered
Algorithmic fix allows ultra-accurate sequencing of rare cancers and genetic conditions
-
BusinessLilly and CureVac to collaborate on mRNA cancer vaccines
Deal could see CureVac net up to $1.8 billion in upfront and milestone payments
-
PodcastAflatoxins
Kat Arney investigates the cancer-causing chemicals that could be lurking in that bag of peanuts
-
ResearchPeptide vehicle drives Crispr delivery of Cas9 into cells
Gene editing enzyme ferried via endocytic pathway
-
ResearchCrispr gene editor can now alter RNA as well as DNA
Gene editing technique is developing apace with two new technologies unveiled
-
-
OpinionRise of the biologics
Antibodies, RNA and gene therapy don’t necessarily compete with small molecule drugs – and they all rely on chemistry
-
-
PodcastA Crack in Creation by Jennifer Doudna – Book club
The development of Crispr, and the ethical questions raised by new genome editing techniques
-
-
ResearchQuick test on pinprick of blood could help stop Ebola in its tracks
Portable Raspberry Pi-based device accurately detects viruses in micro droplet of whole blood
-
BusinessUS to invest $160m in cancer partnership
Funds will be backed up with $55m from 11 companies to advance new cancer treatments that harness the immune system